Madrigal Pharmaceuticals Inc banner

Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 444.83 USD 1.39% Market Closed
Market Cap: $10.1B

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 671.77 USD with a low forecast of 534.29 USD and a high forecast of 1 012.2 USD.

Lowest
Price Target
534.29 USD
20% Upside
Average
Price Target
671.77 USD
51% Upside
Highest
Price Target
1 012.2 USD
128% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
ESQ
Esquire Financial Holdings Inc
12% Upside
SUPN
Supernus Pharmaceuticals Inc
25% Upside
TCPC
BlackRock TCP Capital Corp
83% Upside
VINP
Vinci Partners Investments Ltd
40% Upside

Revenue
Forecast

41% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
41% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 14 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 41%. The projected CAGR for the next 3 years is 48%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
671.77 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 671.77 USD with a low forecast of 534.29 USD and a high forecast of 1 012.2 USD.

What is Madrigal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
48%

For the last 14 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 41%. The projected CAGR for the next 3 years is 48%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett